Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition) ›› 2025, Vol. 12 ›› Issue (01): 7-14. doi: 10.3877/cma.j.issn.2095-7157.2025.01.003

• Guideline • Previous Articles     Next Articles

Expert consensus on perioperative management of super m inimally invasive surgery in patients receiving antithrombotic therapy (2025,Beijing)

Society of Digestive Endoscopology Chinese1   

  1. 1. Chinese Society of Digestive Endoscopology,Beijing 100700,China
  • Received:2025-02-05 Online:2025-02-15 Published:2025-04-11

Abstract:

With the increasing incidence of cardiovascular diseases and population aging,antithrombotic drugs have been widely used in China.However,the management of antithrombotic medications in patients undergoing super minimally invasive surgery (SMIS) still faces significant challenges.Based on domestic and international evidence-based medical research,experts from the Chinese Society of Digestive Endoscopology have developed the consensus on perioperative management of antithrombotic therapy in patients undergoing SMIS through extensive discussions.This consensus presents 10 recommendation items covering preoperative evaluation,antithrombotic medication management,surgical risk stratification,and perioperative gastrointestinal protection strategies for SMIS patients.It aims to optimize patient management during SMIS procedures while achieving optimal therapeutic outcomes and ensuring treatment safety.

Key words: Super minimally invasive surgery, Antithrombotic drugs, Perioperative management, Bleeding risk, Thrombotic risk, Expert consensus

京ICP备07035254号-14
Copyright © Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), All Rights Reserved.
Tel: 010-68295401 E-mail: zhwcnj@163.com
Powered by Beijing Magtech Co. Ltd